Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PRANDIN safely and effectively. See full prescribing information for PRANDIN. Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
PRANDIN is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: PRANDIN should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
- generic_name
- repaglinide
- product_names
- repaglinide
- ndc
- 68151-3565, 0169-0081, 68151-3565-8
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en